Alejandra Dávila-Barclay
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Alejandra Dávila-Barclay has a total of 78 co-authors. Here are the top co-authors by number of shared publications:
- Pablo Tsukayama
Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia
7 shared publications - Guillermo Salvatierra
One Health Research Laboratory, Faculty of Health Sciences, Universidad Privada del Norte, Peru
6 shared publications Diego Cuicapuza
Instituto de Medicina Tropical "Alexander von Humboldt", Universidad Peruana Cayetano Heredia, Lima, Peru
4 shared publications- Pedro Eduardo Romero
Universidad Nacional Mayor de San Marcos, Lima, Peru
3 shared publications - Diego Cuicapuza
Facultad de Medicina, Universidad Peruana Cayetano Heredia, Lima, Peru
2 shared publications Janet Huancachoque
Universidad Peruana Cayetano Heredia, Lima, Peru
2 shared publications
Latest Publications
- Open Access
One Health genomic epidemiology reveals cryptic transmission and surveillance gaps in a decade-long urban rabies epidemic in Arequipa, Peru
Persistent local foci remain a major barrier to eliminating dog-mediated rabies, yet the processes sustaining transmission at micro-scales, particularly within complex urban systems, remain poorly understood. We apply an integrated One Health genomic epidemiology framework to reconstruct a decade-long rabies virus (RABV) epidemic in Arequipa, Peru. Combining 133 newly generated whole genomes with existing data, we assembled the most comprehensive canine RABV dataset in Latin America and used whole-genome-informed phylogenetic, phylodynamic and landscape analyses to trace the epidemic from its first detection in 2015. Transmission was dominated by a single lineage, estimated to have been introduced around 2012, which circulated for approximately three years before detection. We estimate that only 1–2% of infections are routinely detected, revealing extensive cryptic transmission and highlighting the limitations of case-based metrics for verifying disease freedom. Although additional regional and transboundary introductions were identified, only one resulted in sustained transmission. Within Arequipa city, transmission was highly structured, concentrated in densely populated and socioeconomically deprived areas, and shaped by urban connectivity. Roads and dry water channels facilitated spread, while rivers acted as partial barriers. Our findings demonstrate that rabies persistence reflects interacting processes across spatial scales, from regional introductions to highly structured urban transmission. They highlight the importance of genomic-informed, spatially targeted surveillance and control strategies to identify and address persistent transmission foci and accelerate progress towards elimination. Funding: US National Institute of Allergy and Infectious Diseases, US Fogarty International Center, Wellcome Trust, UK Medical Research Council, and UK Engineering and Physical Sciences Research Council.
Open AccessOne Health genomic epidemiology reveals cryptic transmission and surveillance gaps in a decade-long urban rabies epidemic in Arequipa, Peru
Persistent local foci remain a major barrier to eliminating dog-mediated rabies, yet the processes sustaining transmission at micro-scales, particularly within complex urban systems, remain poorly understood. We apply an integrated One Health genomic epidemiology framework to reconstruct a decade-long rabies virus (RABV) epidemic in Arequipa, Peru. Combining 133 newly generated whole genomes with existing data, we assembled the most comprehensive canine RABV dataset in Latin America and used whole-genome-informed phylogenetic, phylodynamic and landscape analyses to trace the epidemic from its first detection in 2015. Transmission was dominated by a single lineage, estimated to have been introduced around 2012, which circulated for approximately three years before detection. We estimate that only 1–2% of infections are routinely detected, revealing extensive cryptic transmission and highlighting the limitations of case-based metrics for verifying disease freedom. Although additional regional and transboundary introductions were identified, only one resulted in sustained transmission. Within Arequipa city, transmission was highly structured, concentrated in densely populated and socioeconomically deprived areas, and shaped by urban connectivity. Roads and dry water channels facilitated spread, while rivers acted as partial barriers. Our findings demonstrate that rabies persistence reflects interacting processes across spatial scales, from regional introductions to highly structured urban transmission. They highlight the importance of genomic-informed, spatially targeted surveillance and control strategies to identify and address persistent transmission foci and accelerate progress towards elimination. Funding: US National Institute of Allergy and Infectious Diseases, US Fogarty International Center, Wellcome Trust, UK Medical Research Council, and UK Engineering and Physical Sciences Research Council.
- Open Access
- 1 July 2026
- Published by Elsevier in Journal of Global Antimicrobial Resistance
- Vol. 50, 204-208
Genome-confirmed Pluralibacter gergoviae urinary tract infection in a companion animal in Peru
- 1 July 2026
- Published by Elsevier in Journal of Global Antimicrobial Resistance
- Vol. 50, 204-208
Open AccessGenome-confirmed Pluralibacter gergoviae urinary tract infection in a companion animal in Peru
- Open Access
- 9 January 2026
- Published by Springer Nature in Communications Medicine
- Vol. 6 (1) , 22
Genomic epidemiology of SARS-CoV-2 in Peru from 2020 to 2024
Background: Peru recorded one of the world’s highest COVID-19 mortality rates, with nearly 4.5 million reported cases and 220,000 deaths by March 2024. Understanding the emergence and spread of SARS-CoV-2 variants in this context is key to informing effective public health responses. This study describes the genomic diversity, transmission dynamics, and geographic spread of SARS-CoV-2 in Peru from 2020 to 2024. Methods: We analyzed nearly 50,000 high-quality public SARS-CoV-2 genome sequences collected nationwide between March 2020 and March 2024. Phylogeographic and mutational analyses were performed to identify variant lineages, trace their origins, and map viral movements within and beyond Peru. Results: We show that Peru’s epidemic waves were shaped by the emergence of locally evolved variants, including Lambda (C.37), Gamma (P.1.12), and Omicron (XBB.2.6 and DJ.1) sub-lineages. The city of Lima acted as the primary hub for inter-regional spread, accounting for 47.3% of inferred viral movements to other departments, notably Ancash, Cusco, and Piura. Peru was the source of various lineages that spread internationally, primarily to Chile, the USA, and Europe. Mutational analysis highlighted critical mutations in the spike protein, including L452Q and F490S in Lambda, associated with immune evasion and increased transmissibility. Conclusions: This work demonstrates the capacity of genomic surveillance in Peru to detect and track emerging SARS-CoV-2 variants, providing insights into regional and global transmission dynamics in a high-transmission, middle-income country setting. Sustained, cost-effective genomic monitoring, combined with strengthened bioinformatics and laboratory capacity, is essential for pandemic preparedness in resource-limited settings.
- 9 January 2026
- Published by Springer Nature in Communications Medicine
- Vol. 6 (1) , 22
Open AccessGenomic epidemiology of SARS-CoV-2 in Peru from 2020 to 2024
Background: Peru recorded one of the world’s highest COVID-19 mortality rates, with nearly 4.5 million reported cases and 220,000 deaths by March 2024. Understanding the emergence and spread of SARS-CoV-2 variants in this context is key to informing effective public health responses. This study describes the genomic diversity, transmission dynamics, and geographic spread of SARS-CoV-2 in Peru from 2020 to 2024. Methods: We analyzed nearly 50,000 high-quality public SARS-CoV-2 genome sequences collected nationwide between March 2020 and March 2024. Phylogeographic and mutational analyses were performed to identify variant lineages, trace their origins, and map viral movements within and beyond Peru. Results: We show that Peru’s epidemic waves were shaped by the emergence of locally evolved variants, including Lambda (C.37), Gamma (P.1.12), and Omicron (XBB.2.6 and DJ.1) sub-lineages. The city of Lima acted as the primary hub for inter-regional spread, accounting for 47.3% of inferred viral movements to other departments, notably Ancash, Cusco, and Piura. Peru was the source of various lineages that spread internationally, primarily to Chile, the USA, and Europe. Mutational analysis highlighted critical mutations in the spike protein, including L452Q and F490S in Lambda, associated with immune evasion and increased transmissibility. Conclusions: This work demonstrates the capacity of genomic surveillance in Peru to detect and track emerging SARS-CoV-2 variants, providing insights into regional and global transmission dynamics in a high-transmission, middle-income country setting. Sustained, cost-effective genomic monitoring, combined with strengthened bioinformatics and laboratory capacity, is essential for pandemic preparedness in resource-limited settings.
- Open Access
- 1 January 2026
- Published by Microbiology Society in Access Microbiology
- Vol. 8 (1) , 001006.v3
Genomic surveillance of multidrug-resistant Escherichia coli and Klebsiella in clinical and wastewater isolates from a paediatric hospital in Lima, Peru
The environmental spread of antibiotic-resistant bacteria is a growing global health concern, particularly in low- and middle-income countries where limited wastewater treatment infrastructure may facilitate the dissemination of multidrug-resistant (MDR) organisms. Escherichia coli and Klebsiella spp. are clinically significant MDR pathogens commonly associated with healthcare-associated infections and known to carry diverse antimicrobial resistance genes (ARGs). In this study, we conducted genomic and phenotypic analyses of E. coli and Klebsiella spp. isolated from hospital wastewater and paediatric patient samples at a tertiary hospital in Lima, Peru, between 2017 and 2019. A total of 157 isolates were collected ( E. coli , n =113; Klebsiella spp., n =44). Whole-genome sequencing was performed to identify ARGs and assess sequence types (STs). MDR phenotypes were more prevalent among wastewater isolates (73.5%) compared to clinical isolates (56.8%, P =0.014), while extended-spectrum β -lactamase production was more frequent in clinical isolates (52.9 % vs. 13.9 %, P E. coli isolates from urine. Genomic analysis revealed greater sequence type diversity among wastewater isolates, including high-risk STs such as ST10, ST131 and ST405. The Shannon diversity index was higher for wastewater-derived isolates (H=3.45) compared to clinical isolates (H=2.95), indicating a more heterogeneous resistance reservoir. In total, 1,302 resistance gene hits were identified, with clinical isolates carrying significantly more ARGs per genome than wastewater isolates. A small number of shared STs were detected in both sources, suggesting possible overlap in bacterial populations. Our findings highlight the potential role of hospital wastewater as a reservoir of antimicrobial resistance and support the value of integrating environmental and clinical genomic surveillance. Wastewater-based monitoring may inform infection control efforts and guide interventions to curb the spread of AMR within healthcare settings and their surrounding environments.
- 1 January 2026
- Published by Microbiology Society in Access Microbiology
- Vol. 8 (1) , 001006.v3
Open AccessGenomic surveillance of multidrug-resistant Escherichia coli and Klebsiella in clinical and wastewater isolates from a paediatric hospital in Lima, Peru
The environmental spread of antibiotic-resistant bacteria is a growing global health concern, particularly in low- and middle-income countries where limited wastewater treatment infrastructure may facilitate the dissemination of multidrug-resistant (MDR) organisms. Escherichia coli and Klebsiella spp. are clinically significant MDR pathogens commonly associated with healthcare-associated infections and known to carry diverse antimicrobial resistance genes (ARGs). In this study, we conducted genomic and phenotypic analyses of E. coli and Klebsiella spp. isolated from hospital wastewater and paediatric patient samples at a tertiary hospital in Lima, Peru, between 2017 and 2019. A total of 157 isolates were collected ( E. coli , n =113; Klebsiella spp., n =44). Whole-genome sequencing was performed to identify ARGs and assess sequence types (STs). MDR phenotypes were more prevalent among wastewater isolates (73.5%) compared to clinical isolates (56.8%, P =0.014), while extended-spectrum β -lactamase production was more frequent in clinical isolates (52.9 % vs. 13.9 %, P E. coli isolates from urine. Genomic analysis revealed greater sequence type diversity among wastewater isolates, including high-risk STs such as ST10, ST131 and ST405. The Shannon diversity index was higher for wastewater-derived isolates (H=3.45) compared to clinical isolates (H=2.95), indicating a more heterogeneous resistance reservoir. In total, 1,302 resistance gene hits were identified, with clinical isolates carrying significantly more ARGs per genome than wastewater isolates. A small number of shared STs were detected in both sources, suggesting possible overlap in bacterial populations. Our findings highlight the potential role of hospital wastewater as a reservoir of antimicrobial resistance and support the value of integrating environmental and clinical genomic surveillance. Wastewater-based monitoring may inform infection control efforts and guide interventions to curb the spread of AMR within healthcare settings and their surrounding environments.
- Open Access
Timeliness in canine rabies outbreak report and response
Introduction Timely response to zoonotic disease outbreaks is crucial to minimizing their impact on the health and wellbeing of people and animals. Monitoring and improving the speed of response, using established outbreak milestones and timeliness metrics, is key to preventing further spread. Despite training and a decade of expertise in case response, persistent delays in these processes continue to hinder effective outbreak responses. Dog- mediated rabies, a classic One Health challenge, remains a significant public health concern in many parts of the world. In Arequipa, Peru, rabies has re-emerged and caused recurrent outbreaks over the past decade, despite substantial control efforts. Addressing the drivers of these delays is vital for improving rabies control. In this study, we use dog rabies as a model to examine delays in zoonotic outbreak response, as well as potential solutions, applying and adapting the Outbreak Milestones and Timeliness Metrics framework. We calculated the timeliness of rabies surveillance and response activities in Arequipa from 2015 to 2024 and identified key barriers contributing to delays. Methods Using canine rabies outbreak response reports from 2015 to 2024 in Arequipa, Peru, we classified One Health outbreak milestones pertaining to the report and response system and calculated timeliness metrics between key processes. Kruskal-Wallis and Dunn tests were applied to measure delays by process, year, and micro-health network. Qualitative analysis of narrative field reports identified underlying causes of delays. Results The longest delay occurred between the detection of behavior change in dogs and initial reporting, averaging 2.52 days (SD = 2.28), while the shortest delay was between diagnosis and outbreak control, averaging 0.76 days (SD = 0.92). Intermediate delays were observed between report and sample shipment and diagnosis and control with averages of 1.28 days (SD = 1.30) and 1.09 days (SD = 1.38), respectively. Delay-related barriers included dog owners’ lack of awareness and reluctance to report symptoms, logistical challenges in sample collection, and delays in implementing outbreak control measures. Additional barriers included confusion about reporting procedures and reluctance from dog owners to share information about their dogs which hindered timely response. Conclusions Delays in rabies reporting and response in Arequipa are primarily driven by slow reporting following behavior changes in dogs and logistical problems with sample collection and control and containment measures. Although diagnosis and outbreak responses are comparatively more efficient, inconsistencies remain. Strengthening community awareness and engagement for reporting, improving intersectoral coordination between health authorities, and optimizing logistics are critical to reducing delays and improving outbreak control.
Open AccessTimeliness in canine rabies outbreak report and response
Introduction Timely response to zoonotic disease outbreaks is crucial to minimizing their impact on the health and wellbeing of people and animals. Monitoring and improving the speed of response, using established outbreak milestones and timeliness metrics, is key to preventing further spread. Despite training and a decade of expertise in case response, persistent delays in these processes continue to hinder effective outbreak responses. Dog- mediated rabies, a classic One Health challenge, remains a significant public health concern in many parts of the world. In Arequipa, Peru, rabies has re-emerged and caused recurrent outbreaks over the past decade, despite substantial control efforts. Addressing the drivers of these delays is vital for improving rabies control. In this study, we use dog rabies as a model to examine delays in zoonotic outbreak response, as well as potential solutions, applying and adapting the Outbreak Milestones and Timeliness Metrics framework. We calculated the timeliness of rabies surveillance and response activities in Arequipa from 2015 to 2024 and identified key barriers contributing to delays. Methods Using canine rabies outbreak response reports from 2015 to 2024 in Arequipa, Peru, we classified One Health outbreak milestones pertaining to the report and response system and calculated timeliness metrics between key processes. Kruskal-Wallis and Dunn tests were applied to measure delays by process, year, and micro-health network. Qualitative analysis of narrative field reports identified underlying causes of delays. Results The longest delay occurred between the detection of behavior change in dogs and initial reporting, averaging 2.52 days (SD = 2.28), while the shortest delay was between diagnosis and outbreak control, averaging 0.76 days (SD = 0.92). Intermediate delays were observed between report and sample shipment and diagnosis and control with averages of 1.28 days (SD = 1.30) and 1.09 days (SD = 1.38), respectively. Delay-related barriers included dog owners’ lack of awareness and reluctance to report symptoms, logistical challenges in sample collection, and delays in implementing outbreak control measures. Additional barriers included confusion about reporting procedures and reluctance from dog owners to share information about their dogs which hindered timely response. Conclusions Delays in rabies reporting and response in Arequipa are primarily driven by slow reporting following behavior changes in dogs and logistical problems with sample collection and control and containment measures. Although diagnosis and outbreak responses are comparatively more efficient, inconsistencies remain. Strengthening community awareness and engagement for reporting, improving intersectoral coordination between health authorities, and optimizing logistics are critical to reducing delays and improving outbreak control.
- Open Access
- 12 August 2025
- Published by Microbiology Society in Microbial Genomics
- Vol. 11 (8)
Open letter: challenging the removal of key bacteria from the updated 2024 WHO Bacterial Priority Pathogen List
- 12 August 2025
- Published by Microbiology Society in Microbial Genomics
- Vol. 11 (8)
Open AccessOpen letter: challenging the removal of key bacteria from the updated 2024 WHO Bacterial Priority Pathogen List
- Open Access
- 1 February 2022
- Published by MDPI AG in Antibiotics
- Vol. 11 (2) , 190
Antibiotic Use and Resistance Knowledge Assessment of Personnel on Chicken Farms with High Levels of Antimicrobial Resistance: A Cross-Sectional Survey in Ica, Peru
Poultry farming represents Peru’s primary food animal production industry, where antimicrobial growth promoters are still commonly used, exerting selective pressure on intestinal microbial populations. Consumption and direct animal-to-human transmission have been reported, and farmworkers are at high risk of colonization with resistant bacteria. We conducted a cross-sectional survey among 54 farmworkers to understand their current antimicrobial resistance (AMR) awareness in Ica, Peru. To gain insight into the potential work-related risk of exposure to bacteria, we also measured the AMR rates in Escherichia coli isolated among 50 broiler chickens. Farmworkers were unaware of antimicrobial resistance (31.5%) or antibiotic resistance (16.7%) terms. Almost two-thirds (61%) consumed antibiotics during the previous month, and only 42.6% received a prescription from a healthcare professional. A total of 107 E. coli chicken isolates were obtained, showing a high frequency of multidrug-resistant (89.7%) and extended-spectrum beta-lactamase (ESBL) production (71.9%). Among ESBL-producer isolates, 84.4% carried the blaCTX-M gene. Results identified gaps in knowledge that reflect the need for interventions to increase antimicrobial awareness among poultry farmworkers. The high AMR rates among E. coli isolates highlight the need to reduce antimicrobial use in poultry farms. Our findings reveal a critical need for effective policy development and antimicrobial stewardship interventions in poultry production in Ica, Peru.
- 1 February 2022
- Published by MDPI AG in Antibiotics
- Vol. 11 (2) , 190
Open AccessAntibiotic Use and Resistance Knowledge Assessment of Personnel on Chicken Farms with High Levels of Antimicrobial Resistance: A Cross-Sectional Survey in Ica, Peru
Poultry farming represents Peru’s primary food animal production industry, where antimicrobial growth promoters are still commonly used, exerting selective pressure on intestinal microbial populations. Consumption and direct animal-to-human transmission have been reported, and farmworkers are at high risk of colonization with resistant bacteria. We conducted a cross-sectional survey among 54 farmworkers to understand their current antimicrobial resistance (AMR) awareness in Ica, Peru. To gain insight into the potential work-related risk of exposure to bacteria, we also measured the AMR rates in Escherichia coli isolated among 50 broiler chickens. Farmworkers were unaware of antimicrobial resistance (31.5%) or antibiotic resistance (16.7%) terms. Almost two-thirds (61%) consumed antibiotics during the previous month, and only 42.6% received a prescription from a healthcare professional. A total of 107 E. coli chicken isolates were obtained, showing a high frequency of multidrug-resistant (89.7%) and extended-spectrum beta-lactamase (ESBL) production (71.9%). Among ESBL-producer isolates, 84.4% carried the blaCTX-M gene. Results identified gaps in knowledge that reflect the need for interventions to increase antimicrobial awareness among poultry farmworkers. The high AMR rates among E. coli isolates highlight the need to reduce antimicrobial use in poultry farms. Our findings reveal a critical need for effective policy development and antimicrobial stewardship interventions in poultry production in Ica, Peru.
- Open Access
- 31 October 2021
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 9 (2) , e0078921
The Emergence of Sars-CoV-2 Variant Lambda (C.37) in South America
The evolution of SARS-CoV-2 variants with potentially increased transmissibility, virulence, and resistance to antibody neutralization poses new challenges for the control of COVID-19 (1), particularly in low- and middle-income countries (LMICs) where transmission remains high and vaccination progress is still incipient.
- 31 October 2021
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 9 (2) , e0078921
Open AccessThe Emergence of Sars-CoV-2 Variant Lambda (C.37) in South America
The evolution of SARS-CoV-2 variants with potentially increased transmissibility, virulence, and resistance to antibody neutralization poses new challenges for the control of COVID-19 (1), particularly in low- and middle-income countries (LMICs) where transmission remains high and vaccination progress is still incipient.
- Open Access
The Emergence of SARS-CoV-2 Variant Lambda (C.37) in South America
We report the emergence of a novel lineage of SARS-CoV-2 in South America, termed C.37. It presents seven nonsynonymous mutations in the Spike gene (Δ247-253, G75V, T76I, L452Q, F490S, T859N) and a deletion in the ORF1a gene (Δ3675-3677) also found in variants of concern (VOCs) Alpha, Beta, and Gamma. Initially reported in Lima, Peru, in late December 2020, it now accounts for 97% of Peruvian public genomes in April 2021. It is expanding in Chile and Argentina, and there is evidence of onward transmission in Colombia, Ecuador, Mexico, the USA, Germany, and Israel. On June 15, 2021, the World Health Organization designated C.37 as Variant of Interest (VOI) Lambda.
Open AccessThe Emergence of SARS-CoV-2 Variant Lambda (C.37) in South America
We report the emergence of a novel lineage of SARS-CoV-2 in South America, termed C.37. It presents seven nonsynonymous mutations in the Spike gene (Δ247-253, G75V, T76I, L452Q, F490S, T859N) and a deletion in the ORF1a gene (Δ3675-3677) also found in variants of concern (VOCs) Alpha, Beta, and Gamma. Initially reported in Lima, Peru, in late December 2020, it now accounts for 97% of Peruvian public genomes in April 2021. It is expanding in Chile and Argentina, and there is evidence of onward transmission in Colombia, Ecuador, Mexico, the USA, Germany, and Israel. On June 15, 2021, the World Health Organization designated C.37 as Variant of Interest (VOI) Lambda.
- Open Access
- 24 September 2020
- Published by American Society for Microbiology in Microbiology Resource Announcements
- Vol. 9 (39)
Draft Genome Sequence of a New Delhi Metallo-β-Lactamase (NDM-1)-Producing Providencia stuartii Strain Isolated in Lima, Peru
Providencia stuartii is an opportunistic pathogen of the Enterobacteriales order. Here, we report the 4,594,658-bp draft genome sequence of a New Delhi metallo-β-lactamase (NDM-1)-producing Providencia stuartii strain that was isolated from an emergency patient in a private clinic in Lima, Peru.
- 24 September 2020
- Published by American Society for Microbiology in Microbiology Resource Announcements
- Vol. 9 (39)
Open AccessDraft Genome Sequence of a New Delhi Metallo-β-Lactamase (NDM-1)-Producing Providencia stuartii Strain Isolated in Lima, Peru
Providencia stuartii is an opportunistic pathogen of the Enterobacteriales order. Here, we report the 4,594,658-bp draft genome sequence of a New Delhi metallo-β-lactamase (NDM-1)-producing Providencia stuartii strain that was isolated from an emergency patient in a private clinic in Lima, Peru.